Advanced Enzyme Technologies has completed acquisition of additional stake of 15% in JC Biotech, subsidiary (JCB) by way of purchase of 31,06,680 Equity Shares from few selling shareholders of JCB, for a consideration of Rs 21.13 crore i.e. Rs 68 per equity share.
In view of this, the shareholding of the company in JCB has increased from 70% to 85% of paid-up share capital of JCB.
Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.
